Advertisement
Australia markets close in 1 hour 37 minutes
  • ALL ORDS

    8,009.40
    -67.50 (-0.84%)
     
  • ASX 200

    7,772.50
    -66.30 (-0.85%)
     
  • AUD/USD

    0.6677
    +0.0027 (+0.41%)
     
  • OIL

    81.22
    +0.39 (+0.48%)
     
  • GOLD

    2,328.80
    -2.00 (-0.09%)
     
  • Bitcoin AUD

    92,496.90
    +659.80 (+0.72%)
     
  • CMC Crypto 200

    1,281.06
    +31.94 (+2.56%)
     
  • AUD/EUR

    0.6233
    +0.0032 (+0.52%)
     
  • AUD/NZD

    1.0918
    +0.0061 (+0.56%)
     
  • NZX 50

    11,782.97
    +66.53 (+0.57%)
     
  • NASDAQ

    19,701.13
    +226.51 (+1.16%)
     
  • FTSE

    8,247.79
    -33.76 (-0.41%)
     
  • Dow Jones

    39,112.16
    -299.05 (-0.76%)
     
  • DAX

    18,177.62
    -147.96 (-0.81%)
     
  • Hang Seng

    18,069.75
    -3.15 (-0.02%)
     
  • NIKKEI 225

    39,686.18
    +513.03 (+1.31%)
     

Sensus Healthcare, Inc. (SRTS) Crossed Above the 20-Day Moving Average: What That Means for Investors

Sensus Healthcare, Inc. (SRTS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SRTS crossed above the 20-day moving average, suggesting a short-term bullish trend.

The 20-day simple moving average is a popular investing tool. Traders like this SMA because it offers a look back at a stock's price over a shorter period and helps smooth out price fluctuations. The 20-day can also show more trend reversal signals than longer-term moving averages.

Similar to other SMAs, if a stock's price moves above the 20-day, the trend is considered positive, while price falling below the moving average can signal a downward trend.

Moving Average Chart for SRTS
Moving Average Chart for SRTS

SRTS could be on the verge of another rally after moving 46.3% higher over the last four weeks. Plus, the company is currently a Zacks Rank #1 (Strong Buy) stock.

ADVERTISEMENT

Looking at SRTS's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 1 revisions higher for the current fiscal year compared to none lower, and the consensus estimate has moved up as well.

Given this move in earnings estimate revisions and the positive technical factor, investors may want to keep their eye on SRTS for more gains in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Sensus Healthcare, Inc. (SRTS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research